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 Physical inactivity in older adults is a risk factor for developing glucose intolerance and 
impaired skeletal muscle function. Elevated ceramide levels have been linked to metabolic 
disruption and toll-like receptor 4 (TLR4) signaling.  The purpose of this study is to determine if 
short-term physical inactivity, bed rest, affects insulin sensitivity and skeletal muscle levels of 
ceramide biosynthesis gene expression in older adults.  We hypothesize that physical inactivity 
will increase skeletal ceramide biosynthesis expression and decrease Akt phosphorylation in 
older adults. Secondly, 5 days of bed rest will decrease insulin sensitivity and glucose tolerance 
and increase NEFA circulation levels in older adults.  
 Therefore, we recruited 9 healthy male and female older adult participants (age range: 
60-75).  Participants underwent a 5-day bed rest experiment in the Center for Clinical and 
Translational Science at the University of Utah Hospital.  Muscle biopsies and fasting blood 
samples were collected.  OGTTs were performed.    
 We found that 5 days of bed rest in older adults resulted in whole body glucose 
dysregulation, impaired skeletal muscle insulin signaling, and upregulation of markers of 
ceramide biosynthesis (P<0.05). Post bed rest TLR4 abundance was tightly correlated with 
impaired post-prandial insulin and glucose levels.  
 In conclusion, 5 days of bed rest in older adults can increase SPT2 protein expression 
and impair skeletal muscle insulin signaling via Akt phosphorylation.  TLR4-mediated SPT2 
expression after bed rest may be an important link between physical inactivity and glucose 
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Physical inactivity is among the leading causes of cardiovascular disease, type 2 
diabetes, and certain types of cancer, and contributes considerably to the world-wide spread of 
disease, death, and disability (1). Intermittent periods of disuse, such as bed rest, or periods of 
reduced ambulatory activity may have a detrimental effect on metabolic health in older adults (2).  
One of the early indicators of metabolic disturbances following short-term physical inactivity/bed 
rest is systemic insulin resistance (2),(3).  
 Insulin resistance is a factor largely responsible for many metabolic diseases such as 
type 2 diabetes mellitus, hypertension, atherosclerosis, and cancer (4).  Because of the major 
contribution skeletal muscle has on glucose disposal via insulin action, skeletal muscle can have 
significant influence on whole body insulin sensitivity.  However, the cellular mechanisms are 
unclear that link altered muscle insulin sensitivity with decreased physical activity in older adults.   
Toll-like receptor 4 (TLR4) is a proinflammatory receptor, which is activated by several 
ligands such as free fatty acids, and has been proposed to mediate insulin resistance by the 
induction of ceramide biosynthesis (5) (Fig. 1). Therefore, the purpose of this study is to 
determine if short-term physical inactivity in the form of controlled bed rest affects insulin 
sensitivity and skeletal muscle levels of ceramide biosynthesis gene expression in older adults.   
 
Insulin resistance in inactive older adults 
 Older adults are far more likely to be hospitalized, engage in sedentary behavior, or 
experience prolonged recovery due to injury than younger adults.  Physical inactivity, due to 
these events, can lead to insulin resistance (2), (3), (6).  A cross-sectional study by Amati et al. 
showed that insulin sensitivity was not associated with age regardless of whether young and 
older adults were athletes, normal-weight subjects, or obese subjects (7). However, a key 
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observation was that insulin sensitivity was greatest among younger and older athletes and worse 
in younger and older obese subjects.  
A recent study by Drummond and colleagues evaluated insulin impairment (fasting serum 
levels of glucose and insulin) and leg muscle volume (MRI) in active, healthy and inactive, frail 
older women (activity levels were assessed by the Physical Activity Scale for the Elderly) (8).  
Importantly, neither group had any reported underlying medical conditions, including type 2 
diabetes (8).  In the study, researchers observed lower lean mass and higher fasting insulin and 
glucose levels in the inactive versus the active older adults, respectively (8).  Therefore, insulin 
resistance is not associated with age but rather the level of physical activity and worsens with 
obesity (7).  Further, insulin resistance can occur independent of any underlying medical 
condition.   
 
Development of insulin resistance following short-term physical inactivity 
 Insulin resistance develops when a normal dose of insulin is unable to stimulate the 
uptake and storage of glucose within cells while at the same time repressing glucose from leaving 
the liver.  However, because of the large mass of skeletal muscle, this organ has major influence 
on whole body glucose homeostasis.  The importance of lean tissue on insulin sensitivity is 
supported by previous bed rest studies in young healthy adults (9), (10), (11).  Stuart and workers 
found that 7 days of bed rest worsened glucose tolerance and increased endogenous insulin 
secretion by 40% in response to an oral glucose tolerance test (OGTT) in young participants (9).  
Nevertheless, physical inactivity did not alter hepatic glucose output nor was there any 
measureable change in insulin receptor abundances on immune cells (9).  Together, these data 
suggest that short-term physical inactivity-induced, insulin resistance is likely driven by glucose 
impairments in skeletal muscle.   
Insulin resistance is not an event that only occurs over decades of sedentary behavior. 
Rather insulin resistance can occur within days of being inactive.  The time course of insulin 
resistance during short-term physical inactivity is unclear but appears to be around 3 days of bed 
rest (measured at day 3 of a 20-day bed rest study) in young healthy subjects (12) while 2 days of 
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bed rest (13) does not alter insulin sensitivity.  In another 3-day bed rest study involving young 
participants, none of the subjects exhibited impaired glucose tolerance during an OGTT, although 
there was an increase in plasma insulin in response to glucose ingestion (14).  It is unknown if 
older adults develop insulin resistance in less than a week of bed rest like their younger 
counterparts (9).  This is important because a majority of older adults hospitalized for acute 
illness typically spend 5-6 days inactive during hospitalization (15).   
However, it is known that short-term physical inactivity in the form of bed rest of at least 
10 days can significantly impair insulin sensitivity in older adults.  Coker et al. found that 
peripheral and hepatic insulin sensitivity deteriorated significantly following 10 days of controlled 
bed rest in older, overweight individuals (3).  These findings were complemented with an 
elevation in fasting plasma glucose as well as insulin-mediated suppression of glucose production 
(3).  In another study, Breen et al. demonstrated that 14 days of reduced physical activity (from 
5962 to 1413 daily steps) in healthy, normal weight, older men and women induced a significant 
reduction in insulin sensitivity (as measured by an OGTT) and increased fasting levels of insulin 
(2).  Additionally, insulin resistance preceded overt body composition changes and the onset of 
metabolic disease (2), (16).  Taken together, these data suggest that insulin resistance can 
develop within 10 days following a period of controlled bed rest in older adults without any 
reported medical condition.  Even a reduction in daily ambulation can lead to rapid impairments in 
skeletal muscle insulin-mediated sensitivity in healthy older adults.  However, it is unknown if less 
than 10 days of bed rest can induce insulin resistance in healthy older adults.  Further it is 
unknown if the magnitude of insulin resistance to short-term physical inactivity is different 
between young and older adults matched by BMI and prior activity level.   
 
Cell signaling and insulin resistance: Role of Akt in muscle glucose uptake 
Although the literature supports that short periods of physical inactivity can induce insulin 
resistance in older adults, the cellular events that are responsible for dysregulated glucose uptake 
following short-term physical inactivity in older skeletal muscle are not well described. From 
cross-sectional studies, peripheral insulin resistance is characterized by impaired glucose 
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transport (GLUT4 translocation) in skeletal muscle in the presence of hyperglycemic conditions 
(hyperinsulinemic clamp procedure) in adults with type 2 diabetes (17).  Further, impaired GLUT4 
translocation is seen in skeletal muscle of type 2 diabetic patients with peripheral insulin 
resistance, when the hyperinsulinemic clamp technique was used, and the perpetual 
hyperglycemia seen in these patients results in resistance to any further insulin-induced plasma 
membrane-level gain of GLUT4 (17).   
In order to understand mechanisms that are upstream of GLUT4 translocation that may 
be impaired following short-term physical inactivity, a basic understanding of insulin signaling is 
necessary.  Insulin binds to the insulin receptor inducing autophosphorylation of the receptor. The 
activated receptor phosphorylates a family of IRS proteins that provide binding sites for the p85 
subunit of 3-phosphoinositide kinase (18).  Akt/protein kinase B (PKB) and phosphatidylinositol-3-
phosphate dependent kinase1 are serine/threonine kinases that are brought close to each other 
by their interactions with PIP3. The membrane lipid helps to activate Akt/PKB, by making 
conformational changes that uncovers two regulatory phosphorylation sites, Thr308 and Ser473 
(19).  For full activation of Akt/PKB, there must be phosphorylation of Thr308 (in the activation 
loop) and also phosphorylation of Ser473 (in the hydrophobic motif) (20).  In order for insulin-
stimulated translocation of the glucose transporter GLUT4 to the plasma membrane, Akt/PKB 
must phosphorylate AS160 (21).  
Skeletal muscle insulin-resistant individuals and type 2 diabetic patients have impaired 
insulin-stimulated Akt phosphorylation (Thr308 and Ser473), lower insulin-stimulated AS160 
phosphorylation on multiple sites thus leading to impaired GLUT4 translocation (22).  Glycogen 
synthase phosphorylation downstream of Akt is maintained even though there is lower Akt 
phosphorylation (22).  This is evidenced by the impaired glycogen activity in type 2 diabetic 
patients shown as glycogen synthase site 2+2a (in the NH2-terminus) that becomes 
hyperphosphorylated during insulin stimulation whereas in glycogen synthase site 3a (in the 
COOH-terminus), phosphorylation is unchanged (22).  
In terms of short-term periods of physical inactivity that induce insulin resistance, 
dysregulated skeletal muscle Akt signaling can be developed in young subjects after 7 days of 
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bed rest (6).  In this study, bed rest-induced insulin resistance was associated with reduced 
insulin-stimulated muscular glycogen synthase activity and Akt signaling as well as decreased 
GLUT4 protein levels (6).  Taken together, these data suggest that GLUT4 translocation is 
diminished in healthy young skeletal muscle following short-term inactivity whereas molecular 
events associated with insulin resistance are partly related to Akt signaling.  It is unknown if Akt 
signaling is disrupted in skeletal muscle following short-term inactivity (bed rest) in healthy older 
adults.   
 
Cell signaling and insulin resistance: Role of TLR4 signaling and ceramide biosynthesis 
Recent evidence has suggested an alternate mechanism that may be related to   
resistance and deficient Akt signaling in skeletal muscle.  The Toll-like receptor 4 (TLR4) protein 
is a member of the TLR family and has been generally understood as a proinflammatory signaling 
pathway.  Ligands such as saturated fatty acids are recognized by TLR4 to induce a signaling 
cascade leading to the activation of nuclear factor κB (NF-κB) and the production of 
proinflammatory cytokines (5).   
TLR4 is located on the cell surface and the activation of the TLR signaling pathway 
originates from the cytoplasmic Toll/IL-1 receptor (TIR) domain that associates with myeloid 
differentiation primary response 88 (MyD88). Upon TLR4 stimulation by ligands, MyD88 recruits 
IL-1 receptor-associated kinase-4 to TLR4.  Interleukin-1 receptor-associated kinase 1 is 
activated by phosphorylation and associates with TNF receptor associated factor-6, thus 
activating the IκB kinase (IKK) complex and leading to nuclear localization of active NF-κB and 
subsequently upregulates transcription of several pro-inflammatory cytokines (e.g., IL-6, tumor 
necrosis factor-alpha (TNFα), IL-β) (23), (24).  Evidence of activation of this signaling pathway 
was noted following a 7-day bed rest study in healthy older adults in which skeletal muscle TLR4 
protein content and NFkB1 and IL6 gene expression were increased (25).  Their data suggest 
that a proinflammatory response exists during short-term physical inactivity in older adults and 
this may be related to the presence of specific TLR4 ligands (25).  
6 
 
Most individuals with type 2 diabetes have elevated plasma non-esterified fatty acid 
(NEFA) levels, which are associated with skeletal muscle insulin resistance (26).  Even following 
short-term bed rest indications of heighted levels of fatty acids can be observed.  Blanc et al. saw 
a decrease in fasting plasma NEFAs in young adults after 7 days of bed rest (11).  Coker and 
colleagues observed, during a 10-day bed rest study with older overweight adults and by 
performing a multistage insulin infusion, a non-significant decrease in the insulin-mediated 
suppression of free fatty acid-rate-of-appearance after bed rest and, as a result, a small change 
in plasma free fatty acid (FFA) from pre- to post-bed rest (3).  Interesting, Hussey et al. 
demonstrated that an increase in TLR4 expression and flux through the NF-κB pathway, occurred 
following a continuous, mild elevation of plasma NEFA in normal-glucose-tolerant individuals (27).  
Therefore, insulin sensitivity is linked to alterations in the regulation of FFAs and is capable of 
triggering the TLR4/ NF-κB pathway.  However, it is not known if bed rest less than a week in 
older adults results in elevations in circulating levels of NEFAs and if this response is different 
from young adults following the same bed rest time course.      
 The sphingolipid ceramide is a supposed intermediate linking saturated fatty acids to the 
induction of insulin resistance (28).  Holland et al. evaluated the effects of saturated vs. 
unsaturated fats on insulin-stimulated glucose disposal in the muscle of rats.  They determined 
that TLR4 precedes sphingolipids (i.e., ceramide) production and is necessary for de novo 
ceramide synthesis in skeletal muscle (5). These authors revealed that the IKKβ/NF-kB signaling 
is essential for TLR4-mediated insulin resistance and upregulation of biosynthetic genes (e.g., 
CerS, SPT2) involved in ceramide synthesis (5).  Further support comes from preliminary data 
from Dr. Drummond’s laboratory. Dr. Drummond and colleagues investigated the role of TLR4 
and ceramide as a mediator of insulin resistance caused by physical inactivity.  They showed that 
2 weeks of hind limb unloading in mice was sufficient to increase skeletal muscle TLR4/NFκB 
signaling (TLR4, IκBα), ceramide biosynthesis (SPT2), and induce insulin resistance in WT hind 
limb unloaded mice compared to ambulatory control mice.      
 Two mechanisms have been proposed as to how ceramide blocks Akt signaling.  The 
first mechanism consists of ceramide activating protein kinase Cζ (PKCζ), which results in the 
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phosphorylation of Akt at Thr34 (29).  This prevents Akt translocation and recruitment onto 
plasma membranes.  The second mechanism involves ceramide activating Protein phosphatase 
2 (PP2A), which dephosphorylates the Akt kinase (29).  Blocking ceramide accumulation restores 
insulin-stimulated Akt phosphorylation, even in the presence of excess saturated fatty acids (i.e., 
palmitate) (30).  Therefore, ceramide through the TLR4 pathway may be a novel mechanism of 
physical inactivity-induced insulin resistance but it has yet to be determined if genes associated 
with ceramide biosynthesis are upregulated in skeletal muscle of older adults following a short-
term period of bed rest. 
 
Significance of the Problem 
 Skeletal muscle is a vital organ when considering the maintenance of metabolic health 
and functional independence in older adults.  The level of contractile activity of skeletal muscle 
plays an important role in the sensitivity of insulin.  Periods of reduced physical activity, which 
occur with greater frequency in older adults due to illness or hospitalization, may have a 
detrimental effect on metabolic health.  When muscle fibers are simultaneously exposed to 
exogenous fatty acids or lipoprotein-bound triglycerides they become insulin resistant, a 
metabolic state which predisposes individuals to metabolic disorders such as type 2 diabetes. 
Saturated fatty acids (SFAs), induce the formation of sphingolipids, like ceramide, which is potent 
antagonists of insulin action.   
 
Purpose of Research 
This purpose of this study is twofold: 1) To determine if 5 days of physical inactivity (bed 
rest) effects ceramide biosynthesis expression and Akt signaling in older adults skeletal muscle, 
2) To determine if 5 days of bed rest effects insulin sensitivity and glucose tolerance (as 
measured with OGTT, HOMA-IR and Matsuda Index), and NEFA blood circulation levels in 






Five days of bed rest will increase skeletal ceramide biosynthesis expression and 
decrease Akt phosphorylation in older adults. Secondly, 5 days of bed rest will decrease insulin 
sensitivity and glucose tolerance and increase NEFA circulation levels in older adults.  
 
Strengths and limitations 
 This is a well-designed study with strong methods.  The blood samples, used to measure 
fasting levels of insulin, glucose, and fatty acid concentrations, as well as muscle biopsies were 
taken while fasted.  This ensured that the subjects did not have a feeding induced cell signaling 
response.   This study mimics the hospital setting and activity was controlled for.   
The main weakness of this study, as with most human studies, involves the ability to 
recruit subjects.  Since a muscle biopsy is not a painless procedure, many subjects did want to 
participate.  This was a minor concern since we have been successful recruiting participants in 
previous studies.  Also being immobilized throughout the 5 days of bed rest was not desirable for 
the subjects.  Two issues with the design of the study could be called into question.  The OGTT 
was administered on day 4 instead of day 5 of bed rest and the hyperinsulinemic euglycemic 
clamp was not used to measuring insulin stimulation.   
 
Clinical applications 
 The majority of older adults hospitalized for acute illness typically spend 5-6 days inactive 
during hospitalization (15).  Thus, by examining the effects of bed rest on insulin sensitivity and 
the gene expression of ceramide biosynthesis, researchers can begin to develop pharmacological 
interventions to target this pathway and prevent the physical inactivity-induced insulin resistance 







Figure 1: TLR4 and insulin cell signaling in human skeletal muscle 
Objective #1: Determine if Akt signaling and ceramide biosynthesis gene expression of SPT1, 
SPT2, CerS1, CerS2 is altered after 5 days of bed rest in older adults.  







Screening of participants 
We recruited 9 healthy male and female older adult participants (age range: 60-75).  All 
subjects were recruited through advertisements in the Salt Lake City community.  The subjects 
were recreationally active, but were not engaged in any regular exercise training program 
currently, as defined by two or more exercise training sessions of moderate to high intensity 
aerobic or resistance exercise per week.  Exclusion criteria include, but are not limited to: heart, 
lung, blood, vascular, liver, kidney, infectious, oncologic, and neurological diseases.  All subjects 
gave their written informed consent before participating in the study, which was approved by the 
Institutional Review Board of the University of Utah. 
 
Experimental design/bed rest 
Research participants underwent a 5-day bed rest experiment in the Center for Clinical 
and Translational Science at the University of Utah Hospital. Participants arrived at the CCTS at 
0600 on day 1 (with 48h refrainment of intense physical activity) and remained in their hospital 
bed except for bathroom and hygiene privileges until the afternoon of day 5 (~1500). Over the 
bed rest period, non-pharmacological deep venous thrombosis prevention was performed which 
consisted of intermittent lower leg compression devices, compression stockings, and daily 
passive range of motion by a physical therapist.  Bathing and hygiene activities were performed 
at the sink while sitting in a wheel chair.  Toilet privileges were provided with the use of a wheel 
chair and the transportation assistance of the nurses. Adherence to bed rest was continuously 
monitored and reinforced daily by nursing staff and study personnel.  Safety blood samples (PT, 
PTT, d-dimer) were taken in the morning of each day of bed rest under fasting conditions. These
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samples were also used to measure fasting levels of insulin, glucose and fatty acid  
concentrations (see Figure 2 for bed rest timeline). 
 
Muscle biopsy procedure 
After an overnight fast, percutaneous muscle biopsies were collected in the morning of 
the initiation of bed rest day 1 (pre bed rest) and at the same time in the morning of bed rest day 
5 (post bed rest).  Muscle biopsies were taken from the vastus lateralis using aseptic technique, 
local anesthesia (1% lidocaine), and a 5mm Bergström biopsy needle with manual suction.  All 
muscle tissue were immediately blotted and dissected of visible non-muscle tissue, flash-frozen in 
liquid nitrogen and stored at -80˚C.  
 
Oral glucose tolerance test 
On an alternate day before the bed rest study, participants took part in an oral glucose 
tolerance test. Subjects were fasted (~8h).  Plasma glucose and insulin concentrations were 
measured at baseline (immediately before the glucose drink) and at every 15 min for the first hour 
and then every 30 min for the following 2h. The Homeostasis Model Assessment of Insulin 
Resistance (HOMA-IR) was calculated from the fasting plasma glucose and insulin 
concentrations (31).  The Matsuda index was calculated from plasma and glucose levels during 
the OGTT (32).  The oral glucose tolerance test was repeated on day 4 of bed rest to determine 
the effects of bed rest on insulin sensitivity. The HOMA-IR was also calculated on day 5 using the 
fasting blood sample.  
 
Blood insulin and fatty acids concentrations 
Fasting blood samples collected pre bed rest (day 1) and on the morning of day 4-5 were 
used to measure plasma insulin (Millipore) and glucose (YSI).  Fasting blood samples collected 
on day 1 and day 5 were also used to measure plasma NEFAs using the NEFA C enzymatic 
assay kit (WAKO, Neuss, Germany).  Plasma LPS concentration was measured by a 
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Approximately 30mg of frozen muscle was homogenized (1:9, w/v) in a buffer containing: 
50 mM Tris-HCl, 250 mM mannitol, 50 mM NaF, 5 mM sodium pyrophosphate, 1 mM EDTA, 1 
mM EGTA, 1% Triton X-100, pH 7.4, 1 mM DTT, 1 mM benzamidine, 0.1 mM PMSF and 5 μg 
ml−1 soybean trypsin inhibitor. Muscle homogenates were centrifuged, supernatant collected, 
and protein concentration determined using a spectrophotometer (EPOCH; BioTek, Winooski, 
VA). Sample buffer (2X) was added (1:1) to an aliquot of supernatant then the samples were 
boiled for 3 min. An aliquot of protein (40ug) was loaded on a polyacrylamide gel (BioRad, 
Hercules, CA) then separated with SDS-PAGE for 1h at 150V.  Protein was transferred (50V, 1h) 
to a polyvinylidene diflouride membrane then blocked for 45 min at room temperature with 2% 
NFDM in Tris-buffered saline in 0.1% Tween-20 (TBST) on a rocker.  Membranes were incubated 
overnight in a primary antibody solution diluted 1:1000 in 2% NFDM with p-Akt (Ser473 and 
Thr308) antibody from Cell Signaling Technologies (catalog #9271 and #9275).  The next 
morning, blots were rocked in secondary antibody (1:6000; Santa Cruz Biotechnology, Santa 
Cruz, CA) for 1h at room temperature then washed 3x (5 min) with TBST.  Chemiluminescence 
reagent (ECL Plus, GE Healthcare) was applied to each blot then incubated for 5 min at room 
temperature.  Optical density measurement was obtained with a digital imager (ChemiDoc XRS+, 
BioRad).  Membranes that contain phosphorylated proteins were stripped (Restore Western Blot 
Stripping Buffer; Pierce Biotechnlogy, CA) of primary and secondary antibodies then re-probed 
for total Akt (1:1000, catalog #9272, Cell Signaling).  Densitometric analysis was performed using 
Lab version 4.1 software (BioRad). Band density was normalized to an internal control sample 
(loaded in duplicate on each gel).  Replicate samples were averaged and reported as fold change 






Analysis of protein expression in older adult skeletal muscle was conducted using a 
paired t test.  An area under the curve was determined for glucose and insulin values collected 
from the OGTT and were compared before and after bed rest.  Insulin and glucose area under 
the curve obtained from the OGTT and baseline insulin, glucose and NEFA concentrations was 
analyzed using a 2-way ANOVA (Age, Time).  Pearson correlations were used on select muscle 
markers and physiological parameters.  All values were presented as mean ± SE.  Significance 

















The HOMA-IR was calculated from the fasting plasma glucose and insulin 
concentrations.  There was no difference in HOMA-IR (Figure 3) post bed rest (p=0.50).  The 
Matsuda index was calculated from plasma and glucose levels during the OGTT.  Matsuda Index 
(Figure 4) decreased after bed rest. (p=0.02).   
 Glucose levels increased at 60 and 90 min post bed rest during the OGTT when 
compared to pre bed rest (Figure 5A, p<0.05).  Total OGTT glucose AUC was higher for post 
bed rest versus pre bed rest (Figure 5B, p<0.05).  Serum insulin levels during the OGTT were 
elevated after bed rest at all the time points (Figure 6A, P<0.05).  Total insulin AUC tended to be 
higher after bed rest (Figure 6B, P=0.06).   
Fasting NEFA levels were not different after bed rest (Figure 7A, p=0.84).  Nor were 
there any changes in NEFA levels during an OGTT after bed rest (Figure 7B, (Total NEFA AUC: 
p=0.36). Following bed rest, fasting LPS levels did not change but there was a tendency for LPS 
levels to increase when normalized to pre bed rest levels (91%; Figure 8, p=0.09).  
Following bed rest, TLR4 protein expression tended to increase by ~35% (Figure 9A, 
P=0.08), SPT2 increased by ~40% (Figure 9B, P<0.05) and Akt phosphorylation of Ser473 
decreased by ~20% (Figure 9C, P<0.05). No difference was seen in the Akt phosphorylation of 
Thr308 (Figure 9D). 
Finally, we determined the relationship of two of our notable skeletal muscle findings with 
glucose uptake impairment in older adults after bed rest.  We found that after 5 days of bed rest, 
TLR4 protein expression was inversely correlated with the Matsuda index (Figure 10A) and 
positively correlated with insulin AUC (Figure 10B) (P<0.05) but not glucose AUC (Figure 10C). 
In contrast, SPT2 protein expression was not related to either of these physiological parameters 
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(Figures 10D-F). Additionally, HOMA-IR was not correlated with TLR4 (R=0.23) or SPT2 










Figure 4: Matsuda index pre bed rest value 9.4 ± 0.6,  post bed rest value 7.7 ± 0.6 (p=0.02).  
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Figure 5: Glucose. A: Glucose levels higher at 60 and 90 min during the OGTT after bed rest 
compared to pre bed rest (* indicates p<0.05). B: Total glucose AUC was 486.4 for pre bed rest 





































Figure 6: Insulin. A: Serum insulin levels during OGTT before and after bed rest (* indicates 





































Figure 7: NEFA. A: Non Esterified Fatty Acids during OGTT (p=0.84).  B: Total AUC pre bed rest 



































Figure 8: LPS. A: Lipopolysaccharides pre 0.58 ± 0.12 and post bed rest 0.72 ± 0.14 


































Figure 9: Western blots. A: TLR4 protein expression (P=0.08).  B: SPT2 protein expression 
(P<0.05).  C: Akt phosphorylation at Ser473 (P<0.05). D: Akt phosphorylation at Thr308 (NS).  
Data were determined at fasting levels before (Pre) and after (Post) bed rest. Values are 





Figure 10: Correlations. A: Correlation between TLR4 and Matsuda index (p=0.04).                   
B: Correlation between TLR4 and insulin AUC (p=0.03).  C: Correlation between TLR and 
glucose AUC (NS).  D: Correlation between SPT2 and Matsuda index (NS).  E: Correlation 







In the current study, our primary finding was that 5 days of bed rest impaired skeletal 
muscle insulin signaling (Akt phosphorylation) and increased ceramide biosynthesis signaling 
(STP2) protein expression in older adults.  Interestingly, increased TLR4 protein content after bed 
rest was strongly correlated to postprandial glucose and insulin responses.  These data support 
the hypothesis that short-term physical inactivity (i.e., controlled bed rest) alters skeletal muscle 
ceramide biosynthesis expression, and may be related to skeletal muscle insulin sensitivity and 
whole body glucose disposal in older adults.   
Nutritional overload and physical inactivity are two major contributors to metabolic 
disruption.  Unfortunately, less is known of the metabolic consequences of a short duration of 
physical inactivity in older adults.  We show for the first time that a brief period of bed rest in older 
adults can increase SPT2 by ~40%, a critical enzyme responsible for ceramide synthesis.  This 
finding is consistent with a recent study by Holland and colleagues that reported an upregulation 
of SPT2 mRNA following a lipid infusion into skeletal muscle of mice (5).  In another recent study 
by Hansen et al., skeletal muscle cells of mice that were treated with insulin and palmitate elicited 
an accumulation in ceramides due to an increase in expression of SPT2, and when SPT2 was 
knocked out, this prevented an increase in ceramides (33).  Although ceramide was not 
measured in the current study, the importance of SPT2 in regulating de novo ceramide levels can 
be seen in studies that use myriocin, a potent inhibitor of SPT2.  When used, myriocin can 
prevent lipid-induced insulin resistance and ceramide accumulation in skeletal muscle of rodents 
(5), (34).  Ceramide has been tied to insulin resistance and other metabolic abnormalities such as 
atherosclerosis, cardiomyopathy, and diabetes.  One mechanism by which ceramides are 
believed to impair insulin signaling is by inhibiting Akt phosphorylation.  For example, in a study 
by Powell et al., incubation of muscle cells with palmitate promoted intracellular accumulation of
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ceramide and inhibited Akt signaling by activating PKCζ, which negatively regulates Akt by 
suppressing its cell-surface recruitment and phosphorylation (30).  However, when muscle cells 
were incubated with myriocin, this suppressed ceramide synthesis and antagonized the inhibitory 
effect of palmitate on Akt activation and regained insulin stimulated glucose transport (30).  
Therefore, it is plausible that an increase in ceramide production may have participated in the 
~20% reduction in Akt phosphorylation seen in this study following bed rest in older adults.  
However, future studies are needed to evaluate if increased enzyme activity with bed rest results 
in ceramide species accumulation in muscle tissue before these conclusions can be drawn.   
We cannot decipher the cause of increased SPT2 protein expression after bed rest in 
skeletal muscle tissue of older adults. However, it is possible that the TLR4 signaling pathway 
may be partly involved. Holland et al. determined that TLR4 was necessary for de novo ceramide 
synthesis and upregulation of ceramide biosynthesis genes such as SPT2 as determined by 
experiments that injected LPS into skeletal muscle of mice and separate experiments in TLR4 KO 
animals (5).  In our study, we showed a tendency for skeletal muscle TLR4 protein abundance 
and a circulating TLR4 ligand (LPS) to increase after bed rest.  Additionally, there was a strong 
correlation between an increase in TLR4 and altered post prandial glucose metabolism in these 
older adults after bed rest.  Possibly a longer period of bed rest may be required to significantly 
increase TLR4 above pre bed rest levels as seen in a similar, albeit longer, 7-day bed rest study 
in older adults (25).  Alternately, it is possible that a bed rest-induced increase in SPT2 could 
operate through a different TLR protein, since many TLRs and even some IL-receptors signal 
through NFκB.  For example, a previous study in humans showed a transcriptional increase in not 
only skeletal muscle TLR4 but also TLR5 and 6 in response to a 2-day lipid infusion (27).  In 
another study, inhibition of TLR2 in cultured muscle cells of mice resulted in a near complete 
inhibition of palmitate-induced insulin resistance (35).  Finally, activation of the TLR4 signaling 
pathway may occur independent of an increase in TLR4 protein or ligand abundance since many 
of the downstream TLR4 adaptor and signaling molecules (e.g., MyD88, TIRAP, IRAKs, TRAFs) 
are regulated by protein-protein interactions and dimerization steps.  Future studies are needed 
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to evaluate a larger range of TLR proteins and evaluation of downstream signaling proteins within 
the TLR4 pathway with 5 days of bed rest in skeletal muscle of older adults.   
Although a previous study in older adults showed that 10 days of bed rest altered glucose 
handling our study supports that as little as 5 days was sufficient to disrupt post-prandial glucose 
disposal in older adults (as determined by an OGTT and the Matsuda index). This finding may be 
intricately tied to the impaired Akt signaling and increased SPT2 protein abundance we observed 
in skeletal muscle homogenate samples of older adults especially since skeletal muscle is the 
primary source of post-prandial glucose disposal. On the contrary, we did not note any difference 
in the HOMA-IR and post-prandial NEFA disposal as opposed to 10 days of bed rest in older 
adults by Coker et al. (3) and also in an age-related study by Ghosh et al. [36]. These differences 
suggest that 5 days was sufficient to cause skeletal muscle dysfunction but additional days of bed 
rest (e.g., 10d) may affect metabolism of other organs (liver) and alter post-prandial fuel 
utilization. Nonetheless,  our data are important and clinically relevant because: 1) they clearly 
demonstrate the metabolic potency of very short-term bouts of inactivity in older adults; 2) a 
majority of older adults hospitalized for acute illness typically spend ~5 days with low amounts of 
ambulatory activity during hospitalization (15).  Therefore, future studies are needed to evaluate 
inpatients interventions such as early mobility and the minimal amount of contractile activity to 
combat early skeletal muscle metabolic decline in older adults during periods of inactivity such as 
acute hospitalization/bed rest.   
In conclusion, we show for the first time that 5 days of bed rest in older adults can 
increase SPT2 protein expression, a major regulator of ceramide biosynthesis signaling and 
impair skeletal muscle insulin signaling via Akt phosphorylation.  TLR4-mediated SPT2 
expression after bed rest may be an important link between physical inactivity and glucose 
intolerance as evidenced by a positive correlation between increased TLR4 protein content and 
postprandial glucose and insulin responses.  Taken together, these data will be important for 
development of future pharmacological interventions aimed at reducing skeletal muscle TLR4 and 



















SUBJECT CHARACTERISTICS AND PHYSIOLOGICAL PARAMETERS 





      Subject characteristics and physiological parameters before and after bed rest
Pre Bed Rest Post Bed Rest p-value
Age, yrs 66 ± 1 - -
BMI, kg/m2 25 ± 1 - -
Body Weight, kg 71.6 ± 3.9 70 ± 4 <0.01
Total Lean Mass, % 60.3 ± 2 59.1 ± 2 <0.01
Total Fat Mass, % 36.6 ± 2 37.7 ± 2 <0.01
Fasting Glucose, mg/dL 92.5 ± 1.8 93.2 ± 1.5 0.64
Fasting Insulin, μU/mL 5.7 ± 0.4 6.2 ± 0.6 0.54
NEFA, mmoL/L 0.42 ± 0.04 0.4 ± 0.09 0.84
NEFA, % Chg  -  - 1.1 ± 0.17 0.71
High Density Lipoprotein 
(HDL), mg/dL 55.8 ± 3.1 49.8 ± 2.5 0.02
Low Density Lipoprotein 
(LDL), mg/dL 92.7 ± 7.9 97.9 ± 10.1 0.38
Very Low Density 
Lipoprotein, mg/dL 18.7 ± 1.4 21.8 ± 4.7 0.43
LDL/HDL ratio 1.7 ± 0.2 2 ± 0.2 0.04
Total Cholesterol, mg/dL 167.1 ± 8.8 169.2 ± 10.3 0.71
Triglycerides, mg/dL 93.4 ± 7.1 109.8 ± 23.7 0.4
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